<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="163183">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01984996</url>
  </required_header>
  <id_info>
    <org_study_id>P0069</org_study_id>
    <nct_id>NCT01984996</nct_id>
  </id_info>
  <brief_title>Freedom Inguinal Hernia Repair System Study</brief_title>
  <official_title>Freedom Inguinal Hernia Repair System Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Insightra Medical, Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Insightra Medical, Inc.</source>
  <oversight_info>
    <authority>United States: Food and Drug Administration</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The primary objective of this study is to evaluate patient quality-of-life (QOL) after
      inguinal hernia repair. &quot;Carolinas Comfort Scale&quot; (CCS) assessments will be held at regular
      intervals.

      The secondary objective of the study is to follow short-term and long-term study-related
      complications/adverse events.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>December 2013</start_date>
  <primary_completion_date type="Anticipated">December 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>Measure changes from baseline in Carolina Comfort Scale (CCS) scores at specified time intervals</measure>
    <time_frame>1 week, 3, 6, 9, 12, 18, 24, and 36 months.</time_frame>
    <safety_issue>No</safety_issue>
    <description>Measure quality of life for patients undergoing inguinal hernia repair.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Evaluate the 14-day pain and medication log</measure>
    <time_frame>14 days</time_frame>
    <safety_issue>No</safety_issue>
    <description>Patient will record pain score and medications for 14 consecutive days.</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Study-related complications/adverse events</measure>
    <time_frame>3 years</time_frame>
    <safety_issue>No</safety_issue>
  </other_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">150</enrollment>
  <condition>Primary Inguinal Hernia</condition>
  <arm_group>
    <arm_group_label>Freedom ProFlor Inguinal Hernia Implant</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Freedom ProFlor Inguinal Hernia Implant</intervention_name>
    <arm_group_label>Freedom ProFlor Inguinal Hernia Implant</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Scheduled to undergo routine inguinal hernia repair

          -  Competent to give consent

          -  Clinically relevant inguinal hernia (classification: NYHUS I, II, IIIa)

          -  Defect size at operation is between 5mm and 35mm

          -  Diagnosed with unilateral, direct, indirect or mixed inguinal hernia

          -  Primary hernia at the operative site

          -  Male or female

          -  Life expectancy of at least 12 months

          -  At least 18 years of age

        Exclusion Criteria:

          -  Signs of obvious local or systemic infection

          -  Any previous surgery on the hernia operative site

          -  Hernia is not in the inguinal area

          -  Hernia is not identified as indirect or direct

          -  Femoral hernias

          -  Known collagen disorder

          -  Presenting with unstable angina or NYHA class of IV

          -  Known Pregnancy

          -  Active drug user

          -  Recurrence of a repair by any method

          -  Patients with giant inguinoscrotal hernia or abdominal wall defect &gt;35 mm in diameter
             - e.g. large direct or combined inguinal hernia type Nyhus IIIb / EHS P L/M 1/2/3

          -  Immunosuppression, prednisone&gt;15 mg/day, active chemotherapy

          -  End stage renal disease

          -  Abdominal ascites

          -  Skin infection in area of surgical field

          -  BMI &gt;35

          -  Peritoneum cannot be closed
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Karl LeBlanc, M.D., M.B.A., F.A.C.S.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Our Lady of the Lake Regional Medical Center</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Jim Clift, CCRP</last_name>
    <phone>949-215-1835</phone>
    <email>jim@insightra.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Metabolic Clinic and Research Center</name>
      <address>
        <city>Los Angeles</city>
        <state>California</state>
        <zip>90033</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Hector Montero</last_name>
      <email>hmontero@mcrcenter.com</email>
    </contact>
    <investigator>
      <last_name>Faisal Khan, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Our Lady of the Lake Regional Medical Center</name>
      <address>
        <city>Baton Rouge</city>
        <state>Louisiana</state>
        <zip>70808</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ryan Landry</last_name>
      <email>ryan.landry@fmolhs.org</email>
    </contact>
    <investigator>
      <last_name>Karl LeBlanc, MD, MBA, FACS</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Herz Jesu Krankenhaus GmbH</name>
      <address>
        <city>Wien</city>
        <zip>A-1030</zip>
        <country>Austria</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Johannes Zacherl, MD</last_name>
      <email>Johannes.Zacherl@kh-herzjesu.at</email>
    </contact>
    <investigator>
      <last_name>Johannes Zacherl, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Policlinico Tor Vergata</name>
      <address>
        <city>Roma</city>
        <zip>00161</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Dario Venditti, MD</last_name>
      <email>dario.venditti@uniroma2.it</email>
    </contact>
    <investigator>
      <last_name>Dario Venditti, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
    <country>Austria</country>
    <country>Italy</country>
  </location_countries>
  <verification_date>March 2014</verification_date>
  <lastchanged_date>March 4, 2014</lastchanged_date>
  <firstreceived_date>November 4, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Hernia</mesh_term>
    <mesh_term>Hernia, Inguinal</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
